## Clinical Diagnosis This patient has **drug-resistant epilepsy (DRE)** — failure to achieve seizure freedom after adequate trials of ≥2 antiepileptic drugs (AEDs). He has **focal (temporal lobe) epilepsy** with structural lesion (mesial temporal sclerosis) and concordant EEG findings. ## Definition and Epidemiology of Drug-Resistant Epilepsy **Key Point:** Drug-resistant epilepsy is defined as failure of adequate trials of ≥2 AED regimens (either monotherapy or combination) to achieve sustained seizure freedom [cite:ILAE 2010 definition]. **High-Yield:** Approximately **30% of patients with epilepsy** develop DRE. Patients with focal structural lesions (like mesial temporal sclerosis) and early-onset seizures have higher risk of DRE. **Surgical intervention is the only potential cure** for appropriately selected DRE patients. ### Surgical Candidacy Criteria for Temporal Lobe Epilepsy | Criterion | Status in This Patient | |-----------|------------------------| | **Drug-resistant (≥2 failed AED trials)** | ✓ Yes (phenytoin, valproate) | | **Focal seizure onset (EEG/imaging concordance)** | ✓ Yes (left temporal lobe) | | **Structural lesion on MRI** | ✓ Yes (mesial temporal sclerosis) | | **Preserved cognitive function** | ✓ Yes (normal cognition) | | **Seizure frequency adequate for monitoring** | ✓ Yes (8–10/month) | | **No contraindications to surgery** | ✓ Presumed (no mention) | **Clinical Pearl:** Mesial temporal sclerosis with focal temporal lobe seizures is the **most surgically favorable form of epilepsy**, with **60–70% seizure-free outcomes** after anterior temporal lobe resection. ### Pre-Surgical Evaluation Pathway ```mermaid flowchart TD A[Drug-Resistant Epilepsy]:::outcome --> B[Focal seizure semiology + EEG concordance?]:::decision B -->|Yes| C[Structural lesion on MRI?]:::decision B -->|No| D[Multifocal/generalized: consider palliative options]:::action C -->|Yes| E[Video-EEG monitoring for seizure localization]:::action C -->|No| F[Advanced imaging: PET, SPECT, MEG]:::action E --> G[Neuropsychological testing]:::action F --> G G --> H[Surgical consultation & planning]:::action H --> I[Temporal lobe resection]:::action I --> J[60-70% seizure-free outcomes]:::outcome ``` ## Why Video-EEG Monitoring Is the Next Step 1. **Confirms seizure localization:** Ictal EEG (during seizure) is more reliable than interictal EEG and definitively localizes the seizure focus. 2. **Assesses laterality:** Confirms left temporal lobe origin and rules out bilateral or multifocal seizures (which would preclude surgery). 3. **Characterizes seizure semiology:** Helps differentiate temporal vs. extratemporal onset. 4. **Prerequisite for surgical planning:** No neurosurgeon will operate without video-EEG confirmation of focal seizure onset. **Warning:** Simply adding more AEDs (options A, D) in a patient who has already failed 2 adequate trials is unlikely to succeed — only ~5% of DRE patients become seizure-free with additional medical therapy. Monotherapy switches (option C) are also unlikely to work in established DRE. ## High-Yield Summary **Key Point:** DRE + focal structural lesion + concordant EEG = **surgical evaluation is indicated**, not further medical optimization. **Mnemonic: SURGICAL CRITERIA for TLE (Temporal Lobe Epilepsy):** - **S**eizures drug-resistant (≥2 failed trials) - **U**nifocal on EEG (focal onset) - **R**esectable lesion on MRI - **G**ood seizure frequency (adequate for monitoring) - **I**ntact cognition - **C**oncordant imaging & EEG - **A**ge & general health suitable - **L**ateral temporal sclerosis (best prognosis) [cite:Harrison 21e Ch 445; ILAE 2010 Definition]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.